Biotech · Private company
Selecta Biosciences, Inc.
Track this companyFree. Adds Selecta Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- KRYSTEXXA®Phase 2 · Chronic GoutClinicalTrials.gov · fetched Nov 12, 2026
- SEL-037Phase 2 · Gout ChronicClinicalTrials.gov · fetched Nov 12, 2026
- SEL-212Phase 2 · Chronic GoutClinicalTrials.gov · fetched Nov 12, 2026
- SEL-212Phase 2 · Gout ChronicClinicalTrials.gov · fetched Nov 12, 2026
- SEL-302Phase 2 · Methylmalonic Acidemia (MMA)ClinicalTrials.gov · fetched Nov 12, 2026
- SVP-rapamycin (SEL-110)Phase 2 · Gout ChronicClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SEL-302 in Pediatric Subjects With MMAPHASE1_PHASE2 · WITHDRAWN · started Dec 19, 2022ClinicalTrials.gov NCT05778877 · fetched Nov 12, 2026
- A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional TherapyPHASE2 · COMPLETED · started May 7, 2019ClinicalTrials.gov NCT03905512 · fetched Nov 12, 2026
- Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric AcidPHASE2 · COMPLETED · started Oct 1, 2016ClinicalTrials.gov NCT02959918 · fetched Nov 12, 2026